WS016 for lowering high potassium
Part of Hormones & metabolism clinical trials.
This study tests an investigational medicine called WS016 to see if it can safely lower high potassium levels in the blood. High potassium can be dangerous, and this treatment may offer a new option to help manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your blood potassium level must be above 5.0 mmol/L at screening.
- If you can become pregnant, you must have a negative pregnancy test and use contraception during the study.
- You must not be on dialysis.
- You must not have had a heart attack or heart procedure in the last 3 months, and you must not have severe heart failure.
- You must not have severe liver problems or a history of serious drug allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.
This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
Hear when a new Hyperkalemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.